Stock exchange notices

Jordanes AS – Appointment of Jan Bodd as CEO

(Oslo, 25 April 2023) The Board of Directors of Jordanes AS ("Jordanes" or the "Company"), the parent company of Jordanes Investments AS, has today appointed Mr. Jan Bodd as Chief Executive Officer (CEO) of Jordanes. Jan Bodd is the co-founder of Jordanes. The appointment will be effective as of today.

As a result, Mr. Dag Teigland will step down as CEO of Jordanes.

"On behalf of Jordanes, I would like to thank Dag for his hard work. He has done a great job preparing the company for an IPO, but the board believes the Company is better served with one of the founders as CEO going forward. This clearly signifies the commitment of the founders to develop the company for the future" said Stig Sunde, Chairman of the Board of Directors.

For additional information, please contact:

Stig T. Sunde,
Chairman & Co-founder
Phone: +47 932 25 161

About Jordanes AS:
Jordanes is a leading Scandinavian brand house focusing on everyday products and services. With a challenger mindset, we constantly seek to improve Scandinavians’ lives by developing brands that people love.

Since our inception in 2007, we have continuously expanded our portfolio to include iconic brands such as Sørlandschips, Synnøve, Peppes Pizza and Bodylab. Our portfolio today includes more than 30 brands spanning across four complementary business areas: branded foods, international brands, fitness & beauty and casual dining.

Jordanes has more than 2 400 employees across the Scandinavian countries, the UK, and the Baltics together with 10 local production facilities in Norway, Sweden and Denmark.

Our brands reach the Scandinavian consumer across all channels and occasions throughout the day, with small-ticket everyday purchases. We will continue to build a passionate and agile brand house with products that are better for the consumer and the environment.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Documents: